About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
SlkGt(BC0415)Wtsi
gene trap BC0415, Wellcome Trust Sanger Institute
MGI:3858304
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
SlkGt(BC0415)Wtsi/SlkGt(BC0415)Wtsi involves: 129P2/OlaHsd * FVB/N MGI:5693939


Genotype
MGI:5693939
hm1
Allelic
Composition
SlkGt(BC0415)Wtsi/SlkGt(BC0415)Wtsi
Genetic
Background
involves: 129P2/OlaHsd * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
SlkGt(BC0415)Wtsi mutation (0 available); any Slk mutation (56 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• although normal Mendelian ratios are observed at E10.5, E12.5, and E14.5, no homozygous mutant pups are detected at birth
• all homozygotes are completely resorbed by E16.5

growth/size/body
• at E12.5 and E14.5, mutant embryos show a marked reduction in size and cellularity relative to wild-type controls

embryo
• mutant placentae are hypovascular as shown by a markedly reduced H&E staining
• at E12.5, staining for smooth muscle actin revealed thin-walled and enlarged blood vessels in placental tissues
• by E14.5, placental blood vessels have collapsed and are practically absent
• large amounts of maternal blood hemorrhaging are observed around the periphery of the labyrinth, suggesting that the blood vessels are leaky
• at E12.5 and E14.5, proper perfusion of fetal blood is observed throughout the tissue in wild-type placentae but is absent in mutant placentae
• propidium iodide staining of embryo fractions revealed a 3-fold increase in the number of apoptotic cells at E12.5
• immunohistochemical analysis confirmed a marked increase in the levels of active caspase 3 in E12.5 but not in E10.5 mutant embryos
• active caspase 3 staining showed a marked increase in the number of apoptotic cells within the labyrinth and junctional zones at E12.5 and E14.5
• however, no apparent decrease in placenta cellularity is observed, as shown by Ki-67 staining
• no differences in apoptosis or proliferation are observed within the maternal tissue at either E12.5 or E14.5
• 40% of E12.5 and all of E14.5 homozygotes exhibit severe developmental defects; very rare defects are noted at E10.5
• at E14.5, marked developmental delay and abnormal structural organization is noted in the brain, eyes, muscles, viscerae, and limbs
• H&E staining of mutant embryos revealed a 33% reduction in total cellularity at E12.5
• at E12.5 and E14.5, mutant embryos show a marked reduction in size and cellularity relative to wild-type controls
• a large proportion of acellular lesions is seen within the junctional zone at E14.5
• at E12.5, mutant labyrinth cells are less differentiated and do not exhibit the typical syncytiotrophoblast morphology seen in wild-type controls
• a larger proportion of acellular lesions is seen within the labyrinth at E14.5

nervous system
• at E12.5, several of the smaller homozygotes exhibit a larger brain size
• betaIII-tubulin (Tuj-1) immunohistochemistry revealed a marked decrease in the size of the neuronal compartment within the posterior neural tube at E10.5
• although smaller Tuj.1+ compartments are seen at E12.5, Tuj-1 staining revealed significant degeneration and much smaller Tuj-1+ compartments at E14.5
• spatially disorganized Tuj-1+ cell clusters are noted along the vertebral axis at both E12.5 and E14.5
• very little expansion of the DRG compartment is observed at E12.5 and E14.5
• by E12.5 and E14.5, Tuj-1+ DRG are spatially disorganized and aligned in a dorsoventral pattern with the vertebrae, unlike in wild-type embryos

muscle
• at E12.5, anti-myosin heavy chain (MF20) staining revealed a less structured and smaller myogenic compartment with MF20+ myofibers scattered throughout the rib cage area and the back
• at E14.5, MF20+ myofibers are very sparse and entirely unstructured with a poorly developed back musculature
• however, no obvious defects are observed in the early premuscle masses at E10.5

limbs/digits/tail

cardiovascular system
• although vasculature appears normal at E12.5, mutant embryos are devoid of PECAM-1+ blood vessels by E14.5, suggesting vascular collapse and death in older embryos
• mutant placentae are hypovascular as shown by a markedly reduced H&E staining
• at E12.5, staining for smooth muscle actin revealed thin-walled and enlarged blood vessels in placental tissues
• by E14.5, placental blood vessels have collapsed and are practically absent
• large amounts of maternal blood hemorrhaging are observed around the periphery of the labyrinth, suggesting that the blood vessels are leaky
• at E12.5 and E14.5, proper perfusion of fetal blood is observed throughout the tissue in wild-type placentae but is absent in mutant placentae
• homozygotes display hemorrhaging of fetal blood around the outside of the placenta

cellular
• propidium iodide staining of embryo fractions revealed a 3-fold increase in the number of apoptotic cells at E12.5
• immunohistochemical analysis confirmed a marked increase in the levels of active caspase 3 in E12.5 but not in E10.5 mutant embryos
• active caspase 3 staining showed a marked increase in the number of apoptotic cells within the labyrinth and junctional zones at E12.5 and E14.5
• however, no apparent decrease in placenta cellularity is observed, as shown by Ki-67 staining
• no differences in apoptosis or proliferation are observed within the maternal tissue at either E12.5 or E14.5
• in culture, primary MEFs isolated from E12.5 mutant embryos show a reduced proliferation rate relative to wild-type MEFs
• however, the slower growth rate is not accompanied by a significant decrease in cell viability

vision/eye

homeostasis/metabolism
• SLK kinase activity toward histone H1 is reduced by ~80%, suggesting that the SLK-LacZ fusion cannot efficiently phosphorylate exogenous substrates





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory